Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial.

scientific article published on 8 November 2012

Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EURONEURO.2012.10.004
P698PubMed publication ID23141152
P5875ResearchGate publication ID233393365

P50authorGeert DomQ42847201
Lianne SchmaalQ61979666
Wim van den BrinkQ20650402
P2093author name stringErik Fransen
Anna E Goudriaan
Leen Joos
Bernard G C Sabbe
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectplaceboQ269829
modafinilQ410441
P304page(s)948-955
P577publication date2012-11-08
P1433published inEuropean NeuropsychopharmacologyQ15286536
P1476titleEffect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial
P478volume23

Reverse relations

cites work (P2860)
Q38940577Addiction, cognitive decline and therapy: seeking ways to escape a vicious cycle.
Q35952408Associations between regional brain physiology and trait impulsivity, motor inhibition, and impaired control over drinking
Q95586205Cognition and addiction
Q34351761Cognitive control in alcohol use disorder: deficits and clinical relevance
Q42314680Deep Brain Stimulation of the Nucleus Accumbens Core Affects Trait Impulsivity in a Baseline-Dependent Manner
Q90597805Developing neuroscience-based treatments for alcohol addiction: A matter of choice?
Q48510046Does self-control modify the impact of interventions to change alcohol, tobacco, and food consumption? A systematic review
Q97542132Effect of alcohol use disorder family history on cognitive function
Q50721149Effect of modafinil on cognitive functions in alcohol dependent patients: a randomized, placebo-controlled trial.
Q41047504Genetic overlap between impulsivity and alcohol dependence: a large-scale national twin study
Q50250464Impulsivity and Alcohol Dependence Treatment Completion: Is There a Neurocognitive Risk Factor at Treatment Entry?
Q38871336Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial.
Q38200690Impulsivity as a predictor of treatment outcome in substance use disorders: review and synthesis
Q37207282Impulsivity in disorders of food and drug misuse
Q50927123Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial.
Q26771692Neural Circuitry of Impaired Emotion Regulation in Substance Use Disorders
Q35594897Neuroimaging and biomarkers in addiction treatment
Q38832124Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review
Q38664308Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug
Q37140612Risky Decision-Making but Not Delay Discounting Improves during Inpatient Treatment of Polysubstance Dependent Alcoholics
Q38848288The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research
Q41392387The monoamine stabilizer (-)-OSU6162 counteracts downregulated dopamine output in the nucleus accumbens of long-term drinking Wistar rats
Q57020898The neurobiology of impulsivity and substance use disorders: implications for treatment

Search more.